Harmony Biosciences Holdings, Inc.
HRMY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802665
In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Harmony Biosciences Holdings, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 84 | 102 | +18 |
| Shares | 28.0M | 30.9M | +2.94M (+10.5%) |
| Value | $790.3M | $1.19B | +$395.6M (+50.1%) |
New holders (27)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (9)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Burrage Capital Management LLC | 150,000 | $4.23M |
| Norges Bank | 72,800 | $2.06M |
| D. E. Shaw & Co., Inc. | 44,765 | $1.26M |
| Iridian Asset Management LLC | 42,597 | $1.20M |
| Squarepoint Ops LLC | 38,041 | $1.07M |
| Deltec Asset Management LLC | 9,170 | $259.0K |
| FORA Capital, LLC | 835 | $24.0K |
| Point72 Hong Kong Ltd | 374 | $11.0K |
| US Bancorp | 17 | $0 |